Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bioxytran Inc (BIXT)
OTHER OTC:BIXT
Holding BIXT?
Track your performance easily
BIXT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.07 - $0.17
Previous Close$0.09
Volume175.50K
Average Volume (3M)66.56K
Market Cap
$7.93M
Enterprise Value$8.70M
Total Cash (Recent Filing)$34.67K
Total Debt (Recent Filing)$755.00K
Price to Earnings (P/E)―
Beta-0.44
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding85,782,908
10 Day Avg. Volume71,006
30 Day Avg. Volume66,563
Standard Deviation2.72
R-Squared0.00019
Alpha0.58
Financial Highlights & Ratios
Price to Book (P/B)-9.30
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)65.80
P/FCF Ratio54.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-8.52
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bioxytran News
PremiumCompany Announcements
Bioxytran Expands Portfolio with NDPD Pharma Acquisition
PremiumCompany Announcements
Bioxytran Inc Welcomes New Expert to Board, Modifies Stock RightsOwnership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BIXT FAQ
What was Bioxytran Inc’s price range in the past 12 months?
Bioxytran Inc lowest stock price was $0.07 and its highest was $0.17 in the past 12 months.
What is Bioxytran Inc’s market cap?
Currently, no data Available
When is Bioxytran Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bioxytran Inc’s earnings last quarter?
Currently, no data Available
Is Bioxytran Inc overvalued?
According to Wall Street analysts Bioxytran Inc’s price is currently Overvalued.
Does Bioxytran Inc pay dividends?
Bioxytran Inc does not currently pay dividends.
What is Bioxytran Inc’s EPS estimate?
Bioxytran Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioxytran Inc have?
Bioxytran Inc has 85,782,906 shares outstanding.
What happened to Bioxytran Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bioxytran Inc?
Currently, no hedge funds are holding shares in BIXT
---
Bioxytran Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.87%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-15.89%
Trailing 12-Months
Company Description
Bioxytran Inc
BioXyTran, Inc. is a pharmaceutical company, which engages in the development, manufacturing and commercialization of first-in-class treatments to prevent catastrophic brain damage resulting from hypoxic conditions following brain stroke. Its products include BXT-25, an anti-necrosis drug that carries oxygen to tissues when the flow of blood is blocked. The company was founded on October 5, 2017 and is headquartered in Newton, MA.
---
Technical Analysis
ADMA Biologics
―
Brainstorm Cell Therapeutics
―
Cyclacel Pharmaceuticals
―
Galectin Therapeutics
―
---